Clinical trials
Coronary Artery Disease trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
87 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 10 |
| Active, not recruiting | 9 |
| Unknown status | 9 |
| Terminated | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 7 |
| Abbott Medical Devices | 5 |
| Boston Scientific Corporation | 4 |
| AstraZeneca | 3 |
| Biotronik AG | 3 |
| Sahlgrenska University Hospital | 3 |
| Vastra Gotaland Region | 3 |
| Aarhus University Hospital Skejby | 2 |
| Bayer | 2 |
| CSL Behring | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 87 |
| Myocardial Infarction | 12 |
| Myocardial Ischemia | 11 |
| Cardiovascular Diseases | 9 |
| Acute Coronary Syndrome | 6 |
| Angina Pectoris | 6 |
| Atherosclerosis | 6 |
| ST Elevation Myocardial Infarction | 6 |
| Coronary Disease | 5 |
| Coronary Stenosis | 5 |
Trials
Showing 51 to 75 of 87. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.